Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy
Diabetic retinopathy (DR) is a leading cause of blindness in working age adults. The objective of this study is to investigate the effects of vascular endothelial growth factor receptor 1 (VEGFR1) blockade on the complications of DR. Experimental models of diabetes were induced with streptozotocin (...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2015/605946 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832548881295998976 |
---|---|
author | Jianbo He Hong Wang Ying Liu Wen Li Dorothy Kim Hu Huang |
author_facet | Jianbo He Hong Wang Ying Liu Wen Li Dorothy Kim Hu Huang |
author_sort | Jianbo He |
collection | DOAJ |
description | Diabetic retinopathy (DR) is a leading cause of blindness in working age adults. The objective of this study is to investigate the effects of vascular endothelial growth factor receptor 1 (VEGFR1) blockade on the complications of DR. Experimental models of diabetes were induced with streptozotocin (STZ) treatment or Insulin2 gene mutation (Akita) in mice. Protein expression and localization were examined by western blots (WB) and immunofluorescence (IF). mRNA expression was quantified by PCR array and real-time PCR. The activity of VEGFR1 signaling was blocked by a neutralizing antibody called MF1. Vascular leakage was evaluated by measuring the leakage of [3H]-mannitol tracer into the retina and the IF staining of albumin. VEGFR1 blockade significantly inhibited diabetes-related vascular leakage, leukocytes-endothelial cell (EC) adhesion (or retinal leukostasis), expression of intercellular adhesion molecule- (ICAM-) 1 protein, abnormal localization and degeneration of the tight junction protein zonula occludens- (ZO-) 1, and the cell adhesion protein vascular endothelial (VE) cadherin. In addition, VEGFR1 blockade interfered with the gene expression of 10 new cytokines and chemokines: cxcl10, il10, ccl8, il1f6, cxcl15, ccl4, il13, ccl6, casp1, and ccr5. These results suggest that VEGFR1 mediates complications of DR and targeting this signaling pathway represents a potential therapeutic strategy for the prevention and treatment of DR. |
format | Article |
id | doaj-art-4aaf3d0be3094be8a8a3d745f3034689 |
institution | Kabale University |
issn | 2090-004X 2090-0058 |
language | English |
publishDate | 2015-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Ophthalmology |
spelling | doaj-art-4aaf3d0be3094be8a8a3d745f30346892025-02-03T06:12:47ZengWileyJournal of Ophthalmology2090-004X2090-00582015-01-01201510.1155/2015/605946605946Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic RetinopathyJianbo He0Hong Wang1Ying Liu2Wen Li3Dorothy Kim4Hu Huang5Guangxi Tumor Hospital & Institute, Nanning, Guangxi 530021, ChinaDepartment of Ophthalmology, the Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, ChinaChangsha Aier Eye Hospital, Changsha, Hunan 410015, ChinaChangsha Aier Eye Hospital, Changsha, Hunan 410015, ChinaWilmer Eye Institute, Johns Hopkins University School of Medicine, M017 Robert H. and Clarice Smith Building, 400 N Broadway, Baltimore, MD 21287, USAWilmer Eye Institute, Johns Hopkins University School of Medicine, M017 Robert H. and Clarice Smith Building, 400 N Broadway, Baltimore, MD 21287, USADiabetic retinopathy (DR) is a leading cause of blindness in working age adults. The objective of this study is to investigate the effects of vascular endothelial growth factor receptor 1 (VEGFR1) blockade on the complications of DR. Experimental models of diabetes were induced with streptozotocin (STZ) treatment or Insulin2 gene mutation (Akita) in mice. Protein expression and localization were examined by western blots (WB) and immunofluorescence (IF). mRNA expression was quantified by PCR array and real-time PCR. The activity of VEGFR1 signaling was blocked by a neutralizing antibody called MF1. Vascular leakage was evaluated by measuring the leakage of [3H]-mannitol tracer into the retina and the IF staining of albumin. VEGFR1 blockade significantly inhibited diabetes-related vascular leakage, leukocytes-endothelial cell (EC) adhesion (or retinal leukostasis), expression of intercellular adhesion molecule- (ICAM-) 1 protein, abnormal localization and degeneration of the tight junction protein zonula occludens- (ZO-) 1, and the cell adhesion protein vascular endothelial (VE) cadherin. In addition, VEGFR1 blockade interfered with the gene expression of 10 new cytokines and chemokines: cxcl10, il10, ccl8, il1f6, cxcl15, ccl4, il13, ccl6, casp1, and ccr5. These results suggest that VEGFR1 mediates complications of DR and targeting this signaling pathway represents a potential therapeutic strategy for the prevention and treatment of DR.http://dx.doi.org/10.1155/2015/605946 |
spellingShingle | Jianbo He Hong Wang Ying Liu Wen Li Dorothy Kim Hu Huang Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy Journal of Ophthalmology |
title | Blockade of Vascular Endothelial Growth Factor
Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy |
title_full | Blockade of Vascular Endothelial Growth Factor
Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy |
title_fullStr | Blockade of Vascular Endothelial Growth Factor
Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy |
title_full_unstemmed | Blockade of Vascular Endothelial Growth Factor
Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy |
title_short | Blockade of Vascular Endothelial Growth Factor
Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy |
title_sort | blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy |
url | http://dx.doi.org/10.1155/2015/605946 |
work_keys_str_mv | AT jianbohe blockadeofvascularendothelialgrowthfactorreceptor1preventsinflammationandvascularleakageindiabeticretinopathy AT hongwang blockadeofvascularendothelialgrowthfactorreceptor1preventsinflammationandvascularleakageindiabeticretinopathy AT yingliu blockadeofvascularendothelialgrowthfactorreceptor1preventsinflammationandvascularleakageindiabeticretinopathy AT wenli blockadeofvascularendothelialgrowthfactorreceptor1preventsinflammationandvascularleakageindiabeticretinopathy AT dorothykim blockadeofvascularendothelialgrowthfactorreceptor1preventsinflammationandvascularleakageindiabeticretinopathy AT huhuang blockadeofvascularendothelialgrowthfactorreceptor1preventsinflammationandvascularleakageindiabeticretinopathy |